The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,147 | 136,434 | SH | SOLE | 136,434 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 792 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| ARCELLX INC | COMMON STOCK | 03940C100 | 3,944 | 210,138 | SH | SOLE | 210,138 | 0 | 0 | ||
| ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 3,465 | 352,500 | SH | SOLE | 352,500 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 10,326 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 8,226 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 5,484 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 3,616 | 400,043 | SH | SOLE | 400,043 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 5,001 | 473,597 | SH | SOLE | 473,597 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 4,437 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 4,491 | 7,500,000 | PRN | SOLE | 7,500,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 2,249 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 975 | 242,517 | SH | SOLE | 242,517 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 16,003 | 813,998 | SH | SOLE | 813,998 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 2,299 | 154,087 | SH | SOLE | 154,087 | 0 | 0 | ||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 981 | 883,654 | SH | SOLE | 883,654 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 4,517 | 1,290,511 | SH | SOLE | 1,290,511 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 3,149 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 17,839 | 326,668 | SH | SOLE | 326,668 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 1,465 | 626,000 | SH | Call | SOLE | 626,000 | 0 | 0 | |
| GERON CORP | COM | 374163103 | 1,521 | 650,000 | SH | Put | SOLE | 650,000 | 0 | 0 | |
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 12,939 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| GSK PLC | SPONSORED ADR | 37733W204 | 2,207 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| GSK PLC | SPONSORED ADR | 37733W204 | 3,237 | 110,000 | SH | Put | SOLE | 110,000 | 0 | 0 | |
| IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 507 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | ||
| INARI MED INC | COM | 45332Y109 | 8,717 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| INVESCO CURRENCYSHARES BRIT | BRIT POUN STRL | 46138M109 | 1,073 | 10,000 | SH | Put | SOLE | 10,000 | 0 | 0 | |
| INVESCO CURRENCYSHARES EURO | EURO SHS | 46138K103 | 1,809 | 20,000 | SH | Put | SOLE | 20,000 | 0 | 0 | |
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | 11,544 | 70,000 | SH | Put | SOLE | 70,000 | 0 | 0 | |
| IVERIC BIO INC | COM | 46583P102 | 538 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,398 | 96,318 | SH | SOLE | 96,318 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 9,231 | 675,753 | SH | SOLE | 675,753 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 507 | 37,100 | SH | Put | SOLE | 37,100 | 0 | 0 | |
| LANTHEUS HLDGS INC | COM | 516544103 | 9,143 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 2,110 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | |
| LIANBIO | SPONSORED ADS | 53000N108 | 1,095 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 6,499 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 4,874 | 75,000 | SH | Put | SOLE | 75,000 | 0 | 0 | |
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 3 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 1,261 | 137,200 | SH | Call | SOLE | 137,200 | 0 | 0 | |
| MORPHIC HLDG INC | COM | 61775R105 | 4,146 | 146,491 | SH | SOLE | 146,491 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 8,544 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 790 | 372,476 | SH | SOLE | 372,476 | 0 | 0 | ||
| PENUMBRA INC | COM | 70975L107 | 4,740 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
| POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 5,771 | 746,576 | SH | SOLE | 746,576 | 0 | 0 | ||
| PRECIGEN INC | NOTE 3.500% 7/0 | 46122TAA0 | 1,455 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 1,475 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| RENOVACOR INC | COM | 75989E106 | 503 | 199,490 | SH | SOLE | 199,490 | 0 | 0 | ||
| RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 6 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 4,274 | 267,794 | SH | SOLE | 267,794 | 0 | 0 | ||
| SANOFI | SPONSORED ADR | 80105N105 | 11,406 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SANOFI | SPONSORED ADR | 80105N105 | 9,505 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 89,295 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 4,993 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 297 | 81,982 | SH | SOLE | 81,982 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 11,131 | 11,000,000 | PRN | SOLE | 11,000,000 | 0 | 0 | ||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 5,935 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADR | 925050106 | 3,577 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADR | 925050106 | 1,687 | 165,100 | SH | Put | SOLE | 165,100 | 0 | 0 | |
| VERVE THERAPEUTICS INC | COM | 92539P101 | 687 | 20,000 | SH | Call | SOLE | 20,000 | 0 | 0 | |
| VICKERS VANTAGE CORP I | *W EXP 09/15/202 | G9440B115 | 17 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 680 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| VINCERX PHARMA INC | COM NEW | 92731L106 | 2,060 | 1,492,771 | SH | SOLE | 1,492,771 | 0 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 3,682 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||